NO20044346L - Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus - Google Patents

Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus

Info

Publication number
NO20044346L
NO20044346L NO20044346A NO20044346A NO20044346L NO 20044346 L NO20044346 L NO 20044346L NO 20044346 A NO20044346 A NO 20044346A NO 20044346 A NO20044346 A NO 20044346A NO 20044346 L NO20044346 L NO 20044346L
Authority
NO
Norway
Prior art keywords
diabetes mellitus
complications
procedures
conditions associated
including conditions
Prior art date
Application number
NO20044346A
Other languages
English (en)
Norwegian (no)
Inventor
P Haydn Pritchard
Tatjana Lukic
Kishor M Wasan
Original Assignee
Forbes Medi Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forbes Medi Tech Inc filed Critical Forbes Medi Tech Inc
Publication of NO20044346L publication Critical patent/NO20044346L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20044346A 2002-03-14 2004-10-13 Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus NO20044346L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9874502A 2002-03-14 2002-03-14
PCT/CA2003/000369 WO2003075931A1 (en) 2002-03-14 2003-03-14 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus

Publications (1)

Publication Number Publication Date
NO20044346L true NO20044346L (no) 2004-12-09

Family

ID=27804294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044346A NO20044346L (no) 2002-03-14 2004-10-13 Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1482950A1 (ru)
JP (1) JP2005528353A (ru)
KR (1) KR20040104513A (ru)
CN (1) CN1681514A (ru)
AU (1) AU2003218547B2 (ru)
BR (1) BR0308396A (ru)
CA (1) CA2478931A1 (ru)
NO (1) NO20044346L (ru)
NZ (1) NZ535200A (ru)
RU (1) RU2334518C2 (ru)
WO (1) WO2003075931A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
KR101823699B1 (ko) * 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
JP2018530319A (ja) * 2015-09-03 2018-10-18 ナチュラル シールド イスラエル ２０１６ リミテッドＮａｔｕｒａｌ Ｓｈｉｅｌｄ Ｉｓｒａｅｌ ２０１６ Ｌｔｄ 血糖値の制御、肝保護、及び関連する病状の予防及び治療のための組み合わせられた組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000653A1 (en) * 1999-06-23 2001-01-04 Forbes Medi-Tech Inc. Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease

Also Published As

Publication number Publication date
JP2005528353A (ja) 2005-09-22
BR0308396A (pt) 2005-01-11
AU2003218547A1 (en) 2003-09-22
CA2478931A1 (en) 2003-09-18
RU2004130463A (ru) 2005-04-10
RU2334518C2 (ru) 2008-09-27
NZ535200A (en) 2007-07-27
WO2003075931A1 (en) 2003-09-18
AU2003218547B2 (en) 2007-11-01
CN1681514A (zh) 2005-10-12
EP1482950A1 (en) 2004-12-08
KR20040104513A (ko) 2004-12-10

Similar Documents

Publication Publication Date Title
IL175949A0 (en) Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxy steroid dehydrogenase type1 (11-beta-hsd-1) for the treatment of diabetes and obesity
EP1799263A4 (en) REDUCTION OF ER-STRESS IN THE TREATMENT OF ADIPOSITAS AND DIABETES
ZA200700904B (en) Method of treating sjögren's syndrome
GB2419529B (en) Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
AU2002322394A1 (en) Method for treating diabetes and obesity
SI1711184T1 (sl) (3-okso-3,4-dihidro-kinoksalin-2-il-amino)-benzamidni derivati in sorodne spojine kot inhibitorji glikogen-fosforilaze za zdravljenje diabetesa in debelosti
HK1068335A1 (en) Novel arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
PL370818A1 (en) Dosage form for treatment of diabetes mellitus
EP1551399A4 (en) METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
IL176259A0 (en) Compositions and methods for treating diabetes
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
EP1924293A4 (en) COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF DIABETES TYPE I
EP1812078A4 (en) KINASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY
EP1774029A4 (en) METHOD FOR DETECTING THE RISKS OF NON-INSULIN-DEPENDENT DIABETES AND FOR TREATING THIS TYPE OF DIABETES
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003236521A8 (en) Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
IL165304A0 (en) Method of treating diabetes
NO20044346L (no) Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
EP1909809A4 (en) METHOD AND COMPOSITION FOR TREATING DIABETES AND ITS COMPLICATIONS
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
AU2006270094A8 (en) Prevention and treatment of ophthalmic complications of diabetes
EP1718294A4 (en) METHODS OF TREATING COMPLICATIONS OF DIABETES
NO20042389L (no) Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette